KaNDy Therapeutics is Biotechnology in United Kingdom that focus on bio-technical research business. Founded in 2017. They cover business area such as Provider, bio-technical research and development service, treatment, female sex-hormone relate condition, non-hormonal therapy, severe post-menopausal vasomotor symptom, patient, hormone-relate condition.
2017
( 7 years old in 2024 )
Bio-technical Research
-
Gunnels Wood Road
HERTS
Stevenage SG1 2FX
England, United Kingdom
Private
Providerbio-technical research and development servicetreatmentfemale sex-hormone relate conditionnon-hormonal therapysevere post-menopausal vasomotor symptompatienthormone-relate condition
* We use standard office opening hours in near KaNDy Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
KaNDy Therapeutics is Biotechnology business from United Kingdom that founded in 2017 (7 years old in 2024), KaNDy Therapeutics business is focusing on Bio-technical Research.
KaNDy Therapeutics headquarter office and corporate office address is located in Gunnels Wood Road HERTS Stevenage SG1 2FX England, United Kingdom.
KaNDy Therapeutics was founded in United Kingdom.
In 2024, KaNDy Therapeutics is currently focus on bio-technical research sector.
Above is snippet of Google Trends for "bio-technical research" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with KaNDy Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.